Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets
Background: Immunotherapies including PD-1/PD-L1 antibodies have been approved for the treatment of Muscle-invasive Bladder Cancer (MIBC) patients. However, immunotherapies could only be beneficial for about 20% MIBC patients. Thus, identification of the immune subtype is becoming increasingly impor...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
Interna Publishing,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!